Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized open-label study of injectable versus oral methotrexate in plaque psoriasis
2006-000509-40Phase 4Completed
- Sponsor
- Gebro Pharma
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methotrexate in plaque psoriasis (2 arms), sponsored by Gebro Pharma. Primary endpoints: Primary efficacy endpoints and Gastric tolerability. Started May 2006; status: completed.
02
Drugs
methotrexate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2006-000509-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000509-40.